MAILAND & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, ein führendes biopharmazeutisches Unternehmen mit Niederlassungen in Italien und den USA, gab heute bekannt, dass es von der US-amerikanischen Food and Drug Administration (FDA) für die Teilnahme am …
Category: Business
Il programma di Dompé sulla NOIA-NA selezionato per il prestigioso programma Commissioner’s National Priority Voucher della FDA
MILANO & SAN MATEO, Calif.–(BUSINESS WIRE)–Dompé, un’azienda biofarmaceutica leader con sedi operative in Italia e negli Stati Uniti, oggi ha annunciato di essere stata selezionata dalla Food and Drug Administration (FDA) statunitense per partecipare…
Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®)
FAR HILLS, N.J.–(BUSINESS WIRE)– #AMD–Samsara Vision Expands U.S. and Puerto Rico Clinical Study Sites for the Smaller-Incision New-Generation Implantable Miniature Telescope (SING IMT®)
IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data analytic solutions, and part of Cencora, can now offer expanded data and insights for oncology, retina and other therapeutic areas. As part of this expansi…
Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery
SINGAPORE–(BUSINESS WIRE)– #glaucoma–Y.ora Vision Launches Following Licensing Agreement Between SERI and Eyexora Global to Advance Minimally Invasive Glaucoma Surgery
Heru Surpasses 1 Million Eyes Tested, Cementing Leadership in AI-Powered Vision Diagnostics
MIAMI–(BUSINESS WIRE)– #automation–Heru, the leader in AI-powered vision diagnostics, today announced it has surpassed a landmark achievement of one million eyes tested on its wearable platform. This significant milestone underscores the company’s a…
Warby Parker to Announce Third Quarter 2025 Financial Results November 6, 2025
NEW YORK–(BUSINESS WIRE)–Warby Parker Inc. (NYSE: WRBY) (the “Company”), a direct-to-consumer lifestyle brand focused on vision for all, today announced that its financial results for the third quarter ended September 30, 2025 will be released before…
Glaukos Innovation to be Highlighted at the 2025 American Academy of Ophthalmology Annual Meeting
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases, announced today that …
Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
LONDON & SEATTLE–(BUSINESS WIRE)– #InvestorConference–Tenpoint Therapeutics, Ltd. to Participate in Four Upcoming Investor Conferences
Tilak Healthcare Obtains Reimbursement for Odysight®, the First Remote Monitoring Solution in Ophthalmology, via the PECAN Progam
PARIS–(BUSINESS WIRE)–Tilak Healthcare, a pioneering company and leader in digital health for chronic eye disease monitoring, announces that it has received a positive opinion from the French National Health Authority (HAS) for the exceptional reimbu…
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA) (“STAAR”), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today provided the following statement in resp…
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
NEW YORK–(BUSINESS WIRE)–Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, has recommended that the shareholders of STAAR Sur…
Howe Innovation Center at Perkins Hosts DisabilityTech Pitch Challenge With Mitsubishi Electric
WATERTOWN, Mass.–(BUSINESS WIRE)–On October 7, the Howe Innovation Center at Perkins School for the Blind hosted a DisabilityTech Pitch Challenge featuring nine start-up companies showcasing their assistive and adaptive technologies to create a more …
Horizon Surgical Systems Completes World’s First Robotic-Assisted Cataract Surgery
LOS ANGELES–(BUSINESS WIRE)–Horizon Surgical Systems (Horizon), a robotics company revolutionizing ophthalmic surgery through the application of robotics and artificial intelligence (AI), today announced the world’s first cataract surgery performed u…
Glaukos to Release Third Quarter 2025 Financial Results after Market Close on October 29
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, plans to release third…
GenSight Biologics Reports Cash Position as of September 30, 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (“GenSight Biologics” or the “Company”) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for ret…
Sightview to Unveil New Design, User Experience at AAO 2025
DURHAM, N.C.–(BUSINESS WIRE)– #EHR–Sightview’s new UI brings workflow and efficiency enhancements, developed and tested with optometrists, ophthalmologists and opticians.
National Vision Launches 2025-2026 Scholarship Program, Spotlighting Technology’s Role in Access to Eye Care
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE), one of the largest optical retail companies in the United States, announced today that its annual scholarship program is open for entries, offering eligible optometry students …
Fuchs Endothelial Corneal Dystrophy Market Report 2025-2035: Epidemiology, Regulatory Landscape, Ongoing Clinical Trials, Market Dynamics, Patent Analysis – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Fuchs Endothelial Corneal Dystrophy Market – A Global and Regional Analysis: Focus on Treatment Method, End User, and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. T…
Presbyopia Market Analysis and Forecast Report 2025-2035 Featuring AbbVie, Eyenovia, Entod Pharma, Lenz Therapeutics, Orasis Pharmaceuticals, and Tenpoint Therapeutics – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Presbyopia Market – A Global and Regional Analysis: Focus on Country and Region – Analysis and Forecast, 2025-2035” report has been added to ResearchAndMarkets.com’s offering. The global presbyopia market is experiencing s…